GGIDX | TOLLX | GGIDX / TOLLX | |
Total Expense Ratio | 0.97 | 1.26 | 77% |
Annual Report Gross Expense Ratio | 1.23 | 1.40 | 88% |
Fund Existence | 9 years | 17 years | - |
Gain YTD | 13.207 | 11.828 | 112% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 101M | 908M | 11% |
Annual Yield % from dividends | 1.92 | 2.19 | 88% |
Returns for 1 year | 2.89 | 9.24 | 31% |
Returns for 3 years | 4.32 | -0.29 | -1,488% |
Returns for 5 years | 22.90 | 16.12 | 142% |
Returns for 10 years | N/A | 40.32 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHLAX | 32.56 | N/A | N/A |
PGIM Jennison Health Sciences A | |||
GCSCX | 20.25 | N/A | N/A |
Goldman Sachs Small Cap Eq Insghts C | |||
HLMOX | 9.10 | N/A | N/A |
Harding Loevner Frontier Emerg Mkts Inv | |||
CISAX | 9.01 | N/A | N/A |
Copeland International Small Cap A | |||
PARWX | 57.32 | -0.17 | -0.30% |
Parnassus Value Equity Investor |